Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Revision History For: PHFR: A $50M Company for .71/Shr ?? Anyone Know ??

No earlier versions found for this Subject.

Return to PHFR: A $50M Company for .71/Shr ?? Anyone Know ??

I came across this company during my research. It's call Pharmaceutical Formulation (PHFR) and reading through their reports...I can't figure out why they are currently at .71/shr..here are some financial stats:
1. 9 months sales $58M (yes, million)
2. 9 months Net income $1m (a penny stock with actual net income!!!)
3. # of shares floating - 30million - or $.03EPS.

This company makes generic and brandname over-the counter pharmaceuticals...asprin, etc. They recently inked another deal.

Given many co. without any sales, let alone sufficent cash for a continued operations, go far higher than this, at .71/share this sounds strange. Check out their 10ks on Edgar. Does anyone know more about this? any comments??